Company Monitoring Page for Acorda-Therapeutics

latest headlines for company on cafepharma

Acorda filed for bankruptcy, and Merz is eyeing its assets
Pharmaphorum
Tue, 04/2/24 - 11:29 am
Tags:
Acorda Therapeutics, Merz, bankruptcy
Biogen returns ex-U.S. rights of MS drug Fampyra to Acorda
Fierce Pharma
Thu, 01/11/24 - 08:45 pm
Tags:
Biogen, Fampyra, MS, multiple sclerosis, Acorda Therapeutics
End-of-Year Restructuring Means Layoffs for These Companies
BioSpace
Tue, 11/16/21 - 11:57 am
Tags:
restructuring, Rigel Pharmaceuticals, Zymergen, Esperion Therapeutics, Amarin, Theravance, Sanofi, Acorda Therapeutics, CureVac, Ziopharm Oncology
Acorda loses its last shot at protecting its cash cow franchise drug. It’s up to Inbrija now
Endpoints
Mon, 10/7/19 - 11:08 am
Tags:
Acorda Therapeutics, AMPYRA, multiple sclerosis, Supreme Court
Acorda Parkinson’s Drug Launched, Exec Hindman Is Now Set to Leave
Xconomy
Fri, 03/8/19 - 10:04 am
Tags:
Acorda Therapeutics, Parkinson's Disease, Andrew Hindman, Inbrija
Battered Acorda pulls off delayed Parkinson’s approval for Inbrija
Fierce Pharma
Wed, 12/26/18 - 04:47 pm
Tags:
Acorda Therapeutics, parkinson's, Inbrija
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/27/18 - 12:16 pm
Tags:
BrainStorm Cell Therapeutics, Allergan, Pfizer, Clovis Oncology, Acorda Therapeutics, Takeda, Agios Pharmaceuticals, Shire, Teva Pharmaceutical, AbbVie
FDA Pushes Back PDUFA Date of Acorda's Parkinson’s Drug
CP Wire
Thu, 09/13/18 - 09:40 am
Tags:
Acorda Therapeutics, Inbrija, Parkinson's Disease, FDA
Thu, 09/13/18 - 09:26 am
Tags:
Acorda Therapeutics, Inbrija, Parkinson's Disease
Federal court rules Ampyra patents invalid, Acorda stock sinks 25%
Biopharma Dive
Mon, 09/10/18 - 11:54 pm
Tags:
Acorda Therapeutics, MS, multiple sclerosis, AMPYRA, patents
Acorda looks to Inbrija launch as Ampyra court battle continues
Biopharma Dive
Fri, 08/3/18 - 10:59 pm
Tags:
Acorda Therapeutics, Inbrija, AMPYRA
Here's Why Acorda Therapeutics Rose as Much as 30.3% Today
Motley Fool
Fri, 06/8/18 - 11:36 pm
Tags:
Acorda Therapeutics, AMPYRA, patents
CEO: Win or lose on Ampyra patents, Acorda reps are safe with Parkinson's prospect
Fierce Pharma
Wed, 06/6/18 - 11:33 am
Tags:
drug reps, layoffs, Acorda Therapeutics, AMPYRA, generics
This biotech CEO’s lousy job performance cost shareholders money, so his board docked his pay
Stat
Mon, 04/30/18 - 09:41 am
Tags:
Acorda Therapeutics, Ron Cohen, executive pay
[forum discussion]Why is Scopia Capital investing in Acorda Therapeutics?
Cafepharma Message Boards
Mon, 03/12/18 - 09:44 am
Tags:
Acorda Therapeutics, Scopia Capital, Inbrija
AbbVie, Allergan, Roche could join Biogen, UCB in Acorda hunt: analyst
Fierce Pharma
Fri, 02/16/18 - 09:38 pm
Tags:
AbbVie, Allergan, Roche, Biogen, UCB Pharma, Acorda Therapeutics, M&A
Acorda posts Q4 revenue beat, but misses EPS estimates
Drug Delivery Business News
Thu, 02/15/18 - 11:39 pm
Tags:
Acorda Therapeutics, earnings
Biogen, UCB step up to kick the tires at Acorda as buyout buzz grows — report
Endpoints
Fri, 01/19/18 - 11:15 am
Tags:
Biogen, UCB Pharma, Acorda Therapeutics, M&A
Acorda writes off $363M drug, axing PhIII Parkinson’s drug in the wake of 5 patient deaths
Endpoints
Mon, 11/20/17 - 09:31 am
Tags:
Acorda Therapeutics, Parkinson's Disease, tozadenant, clinical trials
Acorda faces new trouble with trial halt, safety problems
BioPharma Dive
Wed, 11/15/17 - 08:47 pm
Tags:
Acorda Therapeutics, clinical trials, tozadenant, Parkinson's Disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.